Auto-injector
Latest F. Hoffmann-La Roche AG Patents:
- METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X
- GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy
- Compounds for treating spinal muscular atrophy
- Prefilled syringe and method of preparing a prefilled syringe
- METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X
The auto-injector being shown with inner and outer openings in the rear thereof shown in phantom lines and forming no part of the claimed invention.
The broken line showing of parts of the rear openings of the auto-injector is included for the purpose of illustrating use and environment and forms no part of the claimed design.
Claims
The ornamental design for an auto-injector, as shown and described.
D342134 | December 7, 1993 | Mongeon |
D358882 | May 30, 1995 | Metz et al. |
D364457 | November 21, 1995 | Mongeon |
D395502 | June 23, 1998 | Deily et al. |
D458679 | June 11, 2002 | Thompson et al. |
D472630 | April 1, 2003 | Douglas et al. |
D544600 | June 12, 2007 | Wentling |
D557414 | December 11, 2007 | Wentling |
D578215 | October 7, 2008 | Helder et al. |
D589612 | March 31, 2009 | Sudo |
D591438 | April 28, 2009 | Hama et al. |
D596290 | July 14, 2009 | Kawamura |
D596744 | July 21, 2009 | Hull et al. |
Type: Grant
Filed: May 27, 2009
Date of Patent: May 18, 2010
Assignee: F. Hoffmann-La Roche AG (Basel)
Inventor: Luc Van der Stappen (Mohlin)
Primary Examiner: T. Chase Nelson
Assistant Examiner: David G Muller
Attorney: Levenfeld Pearlstein, LLC
Application Number: 29/337,674